Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 18 studies | 45% ± 19% | |
peripheral blood | 16 studies | 33% ± 12% | |
lung | 13 studies | 25% ± 7% | |
eye | 5 studies | 27% ± 15% | |
bone marrow | 4 studies | 33% ± 11% | |
intestine | 4 studies | 26% ± 6% | |
uterus | 4 studies | 23% ± 10% | |
breast | 4 studies | 16% ± 1% | |
liver | 4 studies | 33% ± 12% | |
adipose | 4 studies | 27% ± 7% | |
heart | 3 studies | 21% ± 4% | |
kidney | 3 studies | 27% ± 4% | |
skin | 3 studies | 19% ± 1% | |
lymph node | 3 studies | 37% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 10713.16 | 244 / 245 | 100% | 44.66 | 502 / 502 |
brain | 100% | 10955.31 | 2631 / 2642 | 100% | 46.41 | 705 / 705 |
thymus | 99% | 8119.79 | 649 / 653 | 100% | 52.70 | 603 / 605 |
ovary | 99% | 4946.39 | 179 / 180 | 100% | 36.45 | 428 / 430 |
skin | 99% | 4935.38 | 1799 / 1809 | 99% | 35.91 | 467 / 472 |
uterus | 100% | 11063.40 | 170 / 170 | 97% | 26.48 | 443 / 459 |
lung | 99% | 5829.53 | 570 / 578 | 97% | 27.03 | 1123 / 1155 |
bladder | 100% | 16839.76 | 21 / 21 | 95% | 20.85 | 480 / 504 |
breast | 96% | 3847.90 | 439 / 459 | 99% | 34.49 | 1111 / 1118 |
esophagus | 100% | 20570.85 | 1443 / 1445 | 93% | 25.25 | 170 / 183 |
intestine | 99% | 17758.10 | 961 / 966 | 90% | 18.48 | 475 / 527 |
kidney | 88% | 3131.98 | 78 / 89 | 96% | 25.21 | 868 / 901 |
adrenal gland | 73% | 2148.80 | 188 / 258 | 91% | 16.04 | 210 / 230 |
stomach | 67% | 5876.62 | 241 / 359 | 91% | 26.39 | 260 / 286 |
liver | 22% | 577.00 | 49 / 226 | 92% | 15.25 | 375 / 406 |
pancreas | 3% | 81.20 | 10 / 328 | 97% | 23.50 | 173 / 178 |
eye | 0% | 0 | 0 / 0 | 100% | 74.07 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 177.78 | 29 / 29 |
spleen | 100% | 11490.25 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 29.68 | 45 / 45 |
blood vessel | 100% | 7310.75 | 1332 / 1335 | 0% | 0 | 0 / 0 |
adipose | 98% | 4682.70 | 1175 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 95% | 17915.32 | 883 / 929 | 0% | 0 | 0 / 0 |
muscle | 67% | 2103.28 | 537 / 803 | 0% | 0 | 0 / 0 |
heart | 45% | 1293.39 | 391 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007165 | Biological process | signal transduction |
GO_0006897 | Biological process | endocytosis |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0005905 | Cellular component | clathrin-coated pit |
GO_0005764 | Cellular component | lysosome |
GO_0005856 | Cellular component | cytoskeleton |
GO_0005829 | Cellular component | cytosol |
GO_0005938 | Cellular component | cell cortex |
GO_0005886 | Cellular component | plasma membrane |
GO_0031410 | Cellular component | cytoplasmic vesicle |
GO_0008289 | Molecular function | lipid binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0005515 | Molecular function | protein binding |
Gene name | FNBP1 |
Protein name | Formin binding protein 1 Formin-binding protein 1 (Formin-binding protein 17) (hFBP17) FNBP1 protein |
Synonyms | FBP17 KIAA0554 |
Description | FUNCTION: May act as a link between RND2 signaling and regulation of the actin cytoskeleton (By similarity). Required to coordinate membrane tubulation with reorganization of the actin cytoskeleton during the late stage of clathrin-mediated endocytosis. Binds to lipids such as phosphatidylinositol 4,5-bisphosphate and phosphatidylserine and promotes membrane invagination and the formation of tubules. Also enhances actin polymerization via the recruitment of WASL/N-WASP, which in turn activates the Arp2/3 complex. Actin polymerization may promote the fission of membrane tubules to form endocytic vesicles. May be required for the lysosomal retention of FASLG/FASL. . |
Accessions | ENST00000449089.7 ENST00000355681.3 [Q96RU3-3] A0A8V8TQ35 ENST00000699492.1 ENST00000703558.1 A0A994J3V8 ENST00000703560.1 H0Y7W6 ENST00000446176.7 [Q96RU3-1] B7ZL13 ENST00000703559.1 A0A994J3U5 B7ZL14 ENST00000703532.1 [Q96RU3-2] A0A994J6U4 Q96RU3 ENST00000703533.1 A0A994J4A3 |